Association of the HLA-DRB1*01 allele with spontaneous viral clearance in an Irish cohort infected with hepatitis C virus via contaminated anti-D immunoglobulin

Seeff, 1997, Natural history of hepatitis C, Hepatology, 26, 21S, 10.1002/hep.510260704 Van der Poel, 1991, Confirmation of hepatitis C virus infection by second generation four-antigen recombinant immunoblot assay and polymerase chain reaction, Lancet, 337, 317, 10.1016/0140-6736(91)90942-I Gordon, 1993, The pathology of hepatitis C as a function of mode of transmission: blood transfusion versus intravenous drug use, Hepatology, 18, 1338, 10.1002/hep.1840180609 Kato, 1993, Quantification of hepatitis C virus by competitive reverse transcription polymerase chain reaction: increase of the virus in advanced liver disease, Hepatology, 18, 16 Okada, 1992, The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients, Hepatology, 16, 619, 10.1002/hep.1840160302 Takada, 1992, Clinical backgrounds of patients having different types of hepatitis C virus genotypes, J Hepatol, 14, 35, 10.1016/0168-8278(92)90128-C Thuraz, 1995, Association between an MHC class II allele and clearance of hepatitis B in the Gambia, N Engl J Med, 332, 1065, 10.1056/NEJM199504203321604 Steel, 1988, HLA haplotype A1 B8 DR3 as a risk factor for HIV related disease, Lancet, i, 1185, 10.1016/S0140-6736(88)92009-0 Aikawa, 1996, HLA DRB1 and DQB1 alleles and haplotypes influencing the progression of hepatitis C, J Med Virol, 49, 274, 10.1002/(SICI)1096-9071(199608)49:4<274::AID-JMV3>3.0.CO;2-0 Hohler, 1997, MHC Class II genes influence the susceptibility to chronic active hepatitis C, J Hepatol, 27, 259, 10.1016/S0168-8278(97)80169-9 Czaja, 1996, DR human leukocyte antigens and disease severity in chronic hepatitis C, J Hepatol, 24, 666, 10.1016/S0168-8278(96)80261-3 Kuzushita, 1998, Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus, Hepatology, 27, 240, 10.1002/hep.510270136 Alric, 1997, Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection, Gasteroenterology, 113, 1675, 10.1053/gast.1997.v113.pm9352872 Cramp, 1998, Association between HLA class II genotype and spontaneous clearance of hepatitis C viremia, J Hepatol, 29, 214, 10.1016/S0168-8278(98)80005-6 Minton, 1998, Association between MHC class II alleles and clearance of circulating hepatitis C virus, J Infect Dis, 178, 39, 10.1086/515599 Power, 1994, Hepatitis C viremia in recipients of Irish intravenous anti-D immunoglobulin, Lancet, 344, 1166, 10.1016/S0140-6736(94)90679-3 1997, Tribunal of Enquiry. Middleton, 1997, Caucasian Northern Irish Normal, 213 Knodell, 1981, Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis, Hepatology, 1, 431, 10.1002/hep.1840010511 Desmet, 1994, Classification of chronic hepatitis: diagnosis, grading and staging, Hepatology, 19, 1513, 10.1002/hep.1840190629 Svejgaard, 1994, HLA and disease association; detecting the strongest association, Tissue Antigens, 43, 18, 10.1111/j.1399-0039.1994.tb02291.x Congia, 1996, HLA class II genes in chronic hepatitis C virus infection and associated immunological disorders, Hepatology, 24, 1338, 10.1002/hep.510240603 Tibbs, 1996, Evidence that the HLA DQA1*03 allele confers protection from chronic HCV infection in Northern European Caucasoids, Hepatology, 24, 1342, 10.1002/hep.510240604 Peano, 1994, HLA-DR5 antigen. A genetic factor influencing the outcome of hepatitis C virus infection, Arch Intern Med, 154, 2733, 10.1001/archinte.1994.00420230126015 Lechmann, 1996, T and B cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus-positive blood donors without viremia, Hepatology, 24, 790 Diepolder, 1995, Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection, Lancet, 346, 1006, 10.1016/S0140-6736(95)91691-1